ReviewReviews in cardiovascular medicine2024

Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease.

Lawrence A Leiter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.